Market Overview

UPDATE: MannKind Posts Wider Q4 Loss

Share:
Related MNKD
MannKind Disappoints Again With Afrezza Sales
MannKind to Manufacture 12 Unit Cartridge Strength of AFREZZA(R) Following FDA Approval
Afrezza Officially 'Unofficially' Hits $1 Million In Sales (Seeking Alpha)

MannKind (NASDAQ: MNKD) posted a wider fourth-quarter loss.

MannKind posted a quarterly loss of $51.8 million, or $0.23 per share, versus a year-ago loss of $36.4 million, or $0.30 per share. However, analysts were expecting a loss of $0.17 per share.

It posted a loss of $169.4 million in 2012.

MannKind shares gained 1.56% to $2.60 in after-hours trading.

Posted-In: lossEarnings News

 

Related Articles (MNKD)

Around the Web, We're Loving...